Abstract:Objective:To study the change of dose distribution by the change of the volume and morphology of the tumor and the normal tissues through the process of the nasopharyngeal carcinoma IMRT. Methods:All 42 patients who were pathologically diagnosed as nasopharyngeal carcinoma from January 2009 to June 2010 were admitted. All patients underwent a simulation CT before the treastment,and the images were uploaded to the Xio treatment therapy system( TPS). The target volume and normal tissues were contoured on the CT image and then the treatment IMRT plan was developed using 6MVX,9 coplanar fields. The dose to the nasopharyngeal tumor and lymph node was 66Gy/30f/6w,dose to the nasopharynx subclinical lesions and neck lymphatic drainage area was 60Gy/30f/6w. Daily or-thogonal images were acquired in the patient treatment position to compare with the DRR of the original treatment planning image,and the patient positionning error was corrected in three dimensions,then the radiation therapy was implemented. Each patient underwent a simulation CT scan weekly to analyse the dose distribution changes of the tar-get and the normal tissues. Concurrent chemotherapy regimen was cisplatin plus docetaxel every 3 weeks,the chemo-therapy was started before the beginning of the radiaotherapy. Results:The average volume of GTV1 was 39. 19cc be-fore radiotherapy,GTV2 was 16. 59cc,at 4th and 6th week of the radiotherapy course the average reduction of GTV1 were 26. 41%,62. 68%,for GTV2 were 28. 43%and 53. 93%respectively. Before treatment,the average volume of bi-lateral parotid was 24. 16cc,at 4th week of radiation therapy,the average volume of parotid was 19. 04cc,at 6th week the average volume of the parotid gland was 17. 54cc. For the does distribution to the normal tissues,in the original plan,spinal cord(D1%),brainstem(D1%),temporal lobe(D1%),the inner ear(Dmean),parotid gland(V30)are(41. 2 ± 0. 98)Gy,(51. 26 ± 1. 57)Gy,(59. 95 ± 2. 11)Gy,(45. 02 ± 1. 98)Gy,(47. 87 ± 18. 05)% respectively,at 4th week of radiotherapy,they are(44. 09 ± 1. 88)Gy,(52. 81 ± 2. 47)Gy,(62. 04 ± 2. 43)Gy,(47. 24 ± 3. 68)Gy, (49. 03 ± 15. 68)%,and at 6th week,(44. 44 ± 2. 7)Gy,(54. 14 ± 2. 51)Gy,(62. 34 ± 2. 86)Gy,(48. 37 ± 5. 37) Gy,(52. 19 ± 15. 51)%. Conclusion:In the nasopharyngeal IMRT process,the actual dose distribution of the tumor will be some difference to the original plan,except one case whose outline contour changes relatively sever because of the shrinkage of the lymph node and the weight loss,the CTV actual dose is above 95%of the prescribed dose,al-though after a few weeks of treatment the tumor target volume and shape changes,the difference was not significant. The dose to the normal tissues in the whole course of treatment will be increased compared with the original plan.

Analysis on Radiation Doses of the Parotid During Intensity-Modulated Radiation Therapy for Nasopharyngeal Carcinoma

[The Relationship Between the Parotid Glands Function and the Dose-Volume Effect in Nasopharyngeal Carcinoma Patients with Intensity-Modulated Radiation Therapy].

Comparison of Quality of Life in Patients with Nasopharyngeal Carcinoma Receiving Conventional External Beam Radiation Therapy Versus Intensity Modulated Radiation Therapy

Influence of intensity-modulated radiation therapy on parotid function in nasopharyngeal carcinoma

Function protection of the parotid gland after intensity modulated radiotherapy for thirty-six patients of nasopharyngeal carcinoma

Relationship between the parotid glands function and the dose-volume effect in nasopharyngeal carcinoma patients with intensity-modulated radiotherapy by radionuclide imaging

Superficial Parotid Lobe-Sparing Delineation Approach: A Better Method Of Dose Optimization To Protect The Parotid Gland In Intensity-Modulated Radiotherapy For Nasopharyngeal Carcinoma

Protection of Parotid Function by Intensity Modulated Radiation Therapy

Dosimetric Evaluation of Hippocampus Sparing Intensity Modulated Radiation Therapy in Patients with Stage T1-T2 and Stage T3-T4 Nasopharyngeal Carcinoma

Analysis of intensity-modulated radiotherapy for untreated patients with nasopharyngeal carcinoma

Actual Anatomical and Dosimetric Changes of Parotid Glands in Nasopharyngeal Carcinoma Patients During Intensity Modulated Radiation Therapy

Intensity-modulated Radiation Therapy in Nasopharyngeal Carcinoma: Virtual Touch Tissue Quantification of Submandibular Gland

Scintigraphic Assessment of Parotid Function Prior to and after IMRT for Pantients with Nasopharygeal Carcinoma

Impact of Anatomical Changes on Dose Distribution of Intensity-Modulated Radiotherapy for Nasopharyngeal Carcinoma

Anatomic and Dosimetric Changes During the Treatment Course of Intensity-Modulated Radiotherapy for Locally Advanced Nasopharyngeal Carcinoma

Volumetric and Geometric Changes of Parotids Occurring During IMRT for Nasopharyngeal Carcinoma(NPC)Using Daily CBCT

Study on dosimetric difference of organ at risk between actual estimated receiving and pretreatment plan during intensity-modulated radiotherapy for nasopharyngeal carcinoma

Preliminary Research on Nasopharyngeal Carcinoma Treated with Intensity-Modulated Radiotherapy

Dose-volume study for tumor and normal tissue of nasopharyngeal carcinoma with IMRT

Dosimetric comparison with conventional radiation therapy and intensity modulated radiation therapy to nasopharyngeal carcinoma

Replanning Criteria and Timing Definition for Parotid Protection-Based Adaptive Radiation Therapy in Nasopharyngeal Carcinoma